The NCSP recommends liver cancer screening every six months for men and women aged 40 years and older who are at high risk for liver cancer such as liver cirrhosis, HBsAg positive, or anti-HCV positive, with alpha-fetoprotein (AFP) and ultrasonography [12]. Here, AFP is linked to liver cancer.